Abstract:Purpose: Tc-99m N-MPO ([Tc-99m N(MPO)(PNP5)](+): HMPO = 2-mercaptopyridine N-oxide, and PNP5 = N-ethoxyethyl-N,N-bis[2-(bis(3-methoxypropyl)phosphino) ethyl] amine) is a new Tc-99m radiotracer useful for myocardial perfusion imaging. This study was designed to determine its pharmacokinetics and biodistribution in healthy volunteers.Patients and Methods: Ten healthy volunteers were involved in this study. Each subject was administered approximately 925 MBq of Tc-99m N-MPO under rest or stress conditions (n = 5 per group). Whole-body planar images were obtained at 10, 30, 60, 240, and 1440 minutes after injection. Organ uptake was quantified by region-of-interest analysis. The blood clearance and urine excretion kinetics were determined by collecting blood and urine samples at different time points.Results: Tc-99m N-MPO showed significant accumulation in myocardium with prolonged retention. At rest, its percentage of injected dose (% ID) uptake in the heart, lungs, and liver at 10 minutes after injection was 2.47% (0.64%), 1.84% (0.64%), and 20.88% (5.23%), respectively. The liver uptake decreased to 6.79% ID (1.60% ID) at 60 minutes after injection and 4.50% ID (1.86% ID) at 240 minutes after injection. Under stress conditions, the heart uptake was slightly increased (2.57% ID [0.21% ID]). The rapid liver clearance led to favorable heart-to-liver ratios, reaching values of 0.27% ID (0.07% ID) under rest condition and 0.28% ID (0.05% ID) under stress condition at 60 minutes after injection.Conclusions: Tc-99m N-MPO demonstrates a highly favorable biodistribution in humans. The high heart uptake and the fast liver washout of Tc-99m N-MPO will allow SPECT images of the left ventricle to be acquired as early as 10 minutes after injection.

Preparation and Prelminary Biodistribution in Mice of 99Mtcn-Bmpbda for Myocardial Perfusion Imaging

Synthesis of New N2S Ligands, Preparation of 99mtc Complexes and Their Preliminary Biodistribution in Mice

Synthesis and biodistribution of a novel [99mTcN(PNP5)(DMCHDTC)]+ complex as a potential myocardial perfusion imaging agent.

PREPARATION AND BIODISTRIBUTION IN MICE OF NEW ~(99m)Tc-NITRIDE HETEROCOMPLEXES

Study of Biodistribution Properties of a New Myocardial Imaging Agent 99Tcm-N-DBODC5

[99Mtcn(pnp5)(noet)]+: A Novel Potential Myocardial Perfusion Imaging Agent

Synthesis And Biodistribution Of A Novel [(Tcn)-Tc-99m(Pnp5)(Dmchdtc)](+) Complex As A Potential Myocardial Perfusion Imaging Agent

[Preclinical Pharmacological Study of a Novel Myocardial Perfusion Agent: 99Mtc-Q3].

Preparation of 99mtcn(cbdtc)2 and Its Biodistribution in Mice.

Experimental Study of [99mtc(pnp5) (DBODC)]+ As a New Myocardial Perfusion Imaging Agent.

Synthesis, separation and biodistribution of99mTc-CO-MIBI complex

Preparation and Biodistribution of the 99mTcN-CPDTC Complex as a New Potential Brain Perfusion Imaging Agent

Preparation and Biological Evaluation of 99Mtc-Co-mibi As Myocardial Perfusion Imaging Agent

Preparation And Biodistribution Of Novel Tc-99m(Co)(3)-Cnr Complexes For Myocardial Imaging

Synthesis and biodistribution of 99m TcN(CHIPDTC) 2 as a potential myocardial perfusion imaging agent

Synthesis, Characterization and Biodistribution of A99mtc Nitrido Complex As a Potential Brain Perfusion Imaging Agent

Synthesis and Evaluation of 18F-Labeled Pyridaben Analogues for Myocardial Perfusion Imaging in Mice, Rats and Chinese Mini-Swine

Comparative Study of Pharmacology of a New Myocardial Imaging Agent [99tcm(co)3(mibi)3]+ and 99 Tcm-MIBI

In-LOOP Synthesis of 11C-Triphenylmethylphosphonium for Myocardial Perfusion Imaging

Preparation of 99mTc-nitrido asymmetrical heterocomplex with 4-(cyclohexylpiperazin-1-yl)-dithioformate and its biological evaluation as a potential myocardial imaging agent.

Pharmacokinetics and Biodistribution of 99mtc N-MPO in Healthy Human Volunteers.